by Team Small News | Sep 27, 2025 | Glenmark, Pharma
Fierce Pharma Asia recently reported on several key developments in the pharmaceutical industry. One major story is Celltrion’s acquisition of a Lilly manufacturing plant in China. This move is expected to enhance Celltrion’s presence in the Chinese market... by Team Small News | Sep 19, 2025 | Glenmark, Pharma
Crisil Ratings has revised the outlook on Glenmark Pharmaceuticals Limited’s long-term bank facilities to ‘Positive’ from ‘Stable’, while reaffirming the rating at ‘Crisil AA’. The short-term rating remains at ‘Crisil...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities.... by Team Small News | Sep 3, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Eribulin Mesylate Injection, 1mg/2mL (0.5 mg/mL) Single-Dose Vials. The product is bioequivalent and therapeutically equivalent to the reference listed drug, Halaven Injection, 1 mg/2 mL (0.5... by Team Small News | Sep 2, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has made a significant breakthrough in the US market by launching the first complex generic cancer drug, Fulvestrant Injection, 250 mg/5 mL (50 mg/mL). This is a generic version of Faslodex, an injectable medication used to treat hormone...
by Team Small News | Aug 25, 2025 | Glenmark, Pharma, Zydus
The High Court of Sikkim has recently overturned a decision by the GST authorities to deny Zydus Wellness budgetary support of ₹59.44 lakh. The court ruled that the rejection was “untenable in law” and went against established judicial precedent. The GST...